MYOS Co. (NASDAQ:MYOS) saw a large increase in short interest in June. As of June 30th, there was short interest totalling 71,100 shares, an increase of 75.1% from the June 15th total of 40,600 shares. Currently, 1.3% of the company’s stock are short sold. Based on an average trading volume of 453,600 shares, the days-to-cover ratio is currently 0.2 days.
NASDAQ:MYOS traded up $0.08 on Tuesday, hitting $1.46. 40,568 shares of the company’s stock traded hands, compared to its average volume of 11,871,864. The company has a market cap of $18.75 million, a PE ratio of -3.95 and a beta of 0.95. The firm has a 50-day moving average price of $1.04 and a 200-day moving average price of $1.13. MYOS has a 1 year low of $0.74 and a 1 year high of $3.85. The company has a current ratio of 2.89, a quick ratio of 1.00 and a debt-to-equity ratio of 0.06.
MYOS (NASDAQ:MYOS) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.29 million during the quarter. MYOS had a negative net margin of 353.71% and a negative return on equity of 176.31%.
MYOS RENS Technology Inc, a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and enhancing the health and performance of muscle tissue. The company primarily focuses on developing the products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity.
Featured Article: What is a stock buyback?
Receive News & Ratings for MYOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYOS and related companies with MarketBeat.com's FREE daily email newsletter.